JCO Oncology Practice Podcast

Dr. Robin Zon of Michiana Hematology and Oncology discusses the latest State of Cancer Care in America report, and the opportunities and challenges confronting the cancer care community.

Dr. David Jackman of Dana-Farber Cancer Institute discusses how after introduction of a clinical pathway in metastatic NSCLC, cost of care decreased significantly with no compromise in survival.

By Dr. Muhammad Beg  Dr. Muhammad Beg discusses the challenges and next steps needed for physical activity monitors to provide relevant information that can change the current state of oncology practice. Related Article:   Promise of Wearable Physical Activity Monitors in Oncology Practice

Dr. Ray Osarogiagbon discusses the need for the development of "real" care teams for lung cancer patients, to foster coordination among the multiple specialists and staff engaged in routine care delivery.

Dr. Robert Miller provides an update on CancerLinQ (Cancer Learning Intelligence Network for Quality), ASCO's big-data, health information technology platform for oncology practices nationwide.

Dr. Pennell talks to co-author Dr. Maria Silveira about why it can be so difficult for oncologists to refuse chemotherapy treatment to patients near death.

This podcast is introducing JOP's new social media editor, Dr. Deanna Attai.

Dr. Horvitz and his co-authors found that signals about patterns of queries in search logs can predict the future appearance of queries that are highly suggestive of a diagnosis of pancreatic adenocarcinoma.

Author Marge Good discusses the results from this project which demonstrate that trial-specific acuity measurement is a better measure of workload than simply counting the number of patients. The ASCO Clinical Trial Workload Assessment Tool was shown to be feasible and useable in diverse community-based research settings.

The author discusses survivorship care, one of the most challenging problems oncologists face today and in the near future. The core curriculum and competencies outline in his manuscript are fundamental to the relatively new field of survivorship care, and provide the framework necessary to generate appropriate referrals depending on local practices and expertise

Journal of Oncology Practice Associate Editor Apar Ganti talks with Consultant Editor Nathan Pennell about what readers can expect to see in the pages of JOP starting in 2016.

A strong brand gives people confidence as they gain awareness of it and come to understand and experience its benefits. The author talks about his suggestion for three steps toward building a better brand for palliative care.

The author shares his experience as an expert witness in an oncology Medicare fraud case in Michigan. 

Dr. Anthony Back, MD, discusses the sobering question raised by McFarland et a l.  The study findings—that inpatient oncology rotations are associated with decreases in interest, empathy, and resilience—suggest that inpatient oncology units have managed to compress into a month a process of hardening previously thought to require years.

The authors discuss key factors to consider that may influence decisions to participate in the Oncology Care Model, by presenting comparable payment reform efforts outside of oncology.

The authors say oncologists should be aware that patients will not find estimates of survival or treatment effect on the Internet, which may contribute to over-optimistic estimates of survival.

The authors discuss the first in a series of articles exploring principles and topics relevant to teams guiding clinicians involved in cancer care. They did not see evidence that multidisciplinary teams affect patient survival or cost of care, and say further research should focus on the association between team processes and structures, efficiency in delivery of care, and mortality.

A discussion with Ron Kline of CMS, which has designed an episode-based model of oncology care that incorporates elements from several successful model tests. It is hoped that this model will demonstrate how oncology care in the US can transform into a high value, high quality system.

  Robert S. Miller, MD. Elaine Towle and Tom Barr discuss the latest National Practice Benchmark Report from Oncology Metrics and review the trends and business climate affecting oncology practices this year.

by Robert S. Miller, MD. Dr. Lee Newcomer of United Healthcare discussed the results of a pilot study of a novel episode payment model coupled with actionable use and quality data as an incentive to improve quality and reduce costs of care.

by Robert S. Miller, MD. Dr. Anees Chagpar discusses findings from the CDC’s 2010 National Health Interview Survey demonstrating a strong correlation between the financial burden of cancer and self-reported quality of life in cancer survivors.

by Robert S. Miller, MD. Dr. Russ Hoverman of Texas Oncology discusses ASCO's and ASTRO's participation in the Choosing Wisely campaign and the important concept of value in oncology.

Stephanie Roberson Barnard discusses her first-person narrative describing the barriers she faced in receiving high-quality, patient-centered care when she was recently treated for breast cancer and some suggestions for improvement.

by Robert S. Miller, MD. Dr. Kerin Adelson discusses the implementation of Epic's Beacon chemotherapy ordering platform at the Tisch Cancer Institute of Mt. Sinai, New York, and introduces a new quality metric called the rate of evidence-based adherence (REBA), used to measure clinic and provider performance and increase evidence-based practice.

by Robert S. Miller, MD. Dr. Reshma Jagsi and collaborators conducted interviews with medical oncologists to ascertain their attitudes toward and prior experiences with the systematic collection of patient-reported outcomes (PROs) in community oncology and to identify barriers to wider implementation.